Skip to main content
. 2021 Oct 18;13(10):1719. doi: 10.3390/pharmaceutics13101719

Figure 4.

Figure 4

Features of (a) in silico (b) in vitro, (c) ex vivo, and (d) in vivo MNP evaluation models.